Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative metformin treatment for colon cancer
2017-000722-35Phase 2Completed
- Sponsor
- Ismail Gögenur
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of metformin in colon cancer (2 arms), sponsored by Ismail Gögenur. Primary endpoints: Change in tumor cell proliferation (Ki67 expression), Change in tumor CD3-positive lymphocyte infiltration and 1 more. Started May 2017; status: completed.
02
Drugs
metformin
03
Conditions
colon cancer
Beyond the preview
Go deeper on 2017-000722-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000722-35.